Post-earnings recap
Reported
Mon, Feb 8, 2010
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.49, exceeding expectations by 12.90%. The stock reacted positively, increasing by 0.11%. However, without additional context from management commentary or guidance, it's challenging to assess the company's future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.49 | N/A | +12.90% |
No transcript is on record, and the analysis is based solely on numerical results.